Page 573 - Read Online
P. 573

Chen et al. Plast Aesthet Res 2020;7:49  I  http://dx.doi.org/10.20517/2347-9264.2020.28                                        Page 11 of 12

                   and fibrosis induces an immunomodulatory phenotype involving CD10-mediated Substance P degradation. Sci Rep 2019;9:10864.
               48.  Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, et al. Regeneration of meniscus cartilage in a knee treated with percutaneously
                   implanted autologous mesenchymal stem cells. Med Hypotheses 2008;71:900-8.
               49.  Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary
                   report of four patients. Int J Rheum Dis 2011;14:211-5.
               50.  Davatchi F, Abdollahi BS, Mohyeddin M, Nikbin B. Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow-up of three
                   patients. Int J Rheum Dis 2016;19:219-25.
               51.  Orozco L, Munar A, Soler R, Alberca M, Soler F, et al. Treatment of knee osteoarthritis with autologous mesenchymal stem cells: two-
                   year follow-up results. Transplantation 2014;97:e66-8.
               52.  Soler R, Orozco L, Munar A, Huguet M, Lopez R, et al. Final results of a phase I-II trial using ex vivo expanded autologous mesenchymal
                   stromal cells for the treatment of osteoarthritis of the knee confirming safety and suggesting cartilage regeneration. Knee 2016;23:647-54.
               53.  Chahal J, Gómez-Aristizábal A, Shestopaloff K, Bhatt S, Chaboureau A, et al. Bone marrow mesenchymal stromal cell treatment in
                   patients with osteoarthritis results in overall improvement in pain and symptoms and reduces synovial inflammation. Stem Cells Transl
                   Med 2019;8:746-57.
               54.  Fodor PB, Paulseth SG. Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint.
                   Aesthet Surg J 2016;36:229-36.
               55.  Yokota N, Hattori M, Ohtsuru T, Otsuji M, Lyman S, et al. Comparative clinical outcomes after intra-articular injection with adipose-
                   derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med
                   2019;47:2577-83.
               56.  Pers YM, Rackwitz L, Ferreira R, Pullig O, Delfour C, et al. ADIPOA Consortium. Adipose mesenchymal stromal cell-based therapy for
                   severe osteoarthritis of theknee: a phase I dose-escalation trial. Stem Cells Transl Med 2016;5:847-56.
               57.  Lee WS, Kim HJ, Kim KI, Kim GB, Jin W. Intra-articular injection of autologous adipose tissue-derived mesenchymal stem cells for the
                   treatment of knee osteoarthritis: a phase IIb, randomized, placebo-controlled clinical trial. Stem Cells Transl Med 2019;8:504-11.
               58.  Lu L, Dai C, Zhang Z, Du H, Li S, et al. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived
                   mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial. Stem Cell Res Ther
                   2019;10:143.
               59.  Chuckpaiwong B, Charles HC, Kraus VB, Guilak F, Nunley JA. Age-associated increases in the size of the infrapatellar fat pad in knee
                   osteoarthritis as measured by 3T MRI. J Orthop Res 2010;28:1149-54.
               60.  Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 2012;19:902-7.
               61.  do Amaral R, Almeida HV, Kelly DJ, O’Brien FJ, Kearney CJ. Infrapatellar fat pad stem cells: from developmental biology to cell
                   therapy. Stem Cells Int 2017;2017:6843727.
               62.  Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, et al. Treatment of osteoarthritis with infrapatellar fat pad derived
                   mesenchymal stem cells in Rabbit. Knee 2011;18:71-5.
               63.  Koh YG, Jo SB, Kwon OR, Suh DS, Lee SW, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis.
                   Arthroscopy 2013;29:748-55.
               64.  Spasovski D, Spasovski V, Bascarevic Z, Stojiljkovic M, Vreca M, et al. Intra-articular injection of autologous adipose-derived
                   mesenchymal stem cells in the treatment of knee osteoarthritis. J Gene Med 2018;20:e3002.
               65.  Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, et al. Human autologous culture expanded bone marrow mesenchymal cell
                   transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002;10:199-206.
               66.  Nejadnik H, Hui JH, Feng Choong EP, Tai BC, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous
                   chondrocyte implantation: an observational cohort study. Am J Sports Med 2010;38:1110-6.
               67.  Haleem AM, Singergy AAE, Sabry D, Atta HM, Rashed LA, et al. The clinical use of human culture-expanded autologous bone
                   marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and
                   preliminary results. Cartilage 2010;1:253-61.
               68.  Teo AQA, Wong KL, Shen L, Lim JY, Toh WS, et al. Equivalent 10-year outcomes after implantation of autologous bone marrow-derived
                   mesenchymal stem cells versus autologous chondrocyte implantation for chondral defects of the knee. Am J Sports Med 2019;47:2881-7.
               69.  Koga H, Shimaya M, Muneta T, Nimura A, Morito T, et al. Local adherent technique for transplanting mesenchymal stem cells as a
                   potential treatment of cartilage defect. Arthritis Res Ther 2008;10:R84.
               70.  Sekiya I, Muneta T, Horie M, Koga H. Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with
                   cartilage defects. Clin Orthop Relat Res 2015;473:2316-26.
               71.  Shimomura K, Ando W, Moriguchi Y, Sugita N, Yasui Y, et al. Next generation mesenchymal stem cell (MSC)-based cartilage repair
                   using scaffold-free tissue engineered constructs generated with synovial mesenchymal stem cells. Cartilage 2015;6:13S-29S.
               72.  Chang CH, Kuo TF, Lin FH, Wang JH, Hsu YM, et al. Tissue engineering-based cartilage repair with mesenchymal stem cells in a porcine
                   model. J Orthop Res 2011;29:1874-80.
               73.  Chen CC, Liao CH, Wang YH, Hsu YM, Huang SH, et al. Cartilage fragments from osteoarthritic knee promote chondrogenesis of
                   mesenchymal stem cells without exogenous growth factor induction. J Orthop Res 2012;30:393-400.
               74.  Chang CH, Chen CC, Liao CH, Lin FH, Hsu YM, et al. Human acellular cartilage matrix powders as a biological scaffold for cartilage
                   tissue engineering with synovium-derived mesenchymal stem cells. J Biomed Mater Res A 2014;102:2248-57.
               75.  Chen CC, Hsiao CY, Wang YH, Chen YC, Chang CH, et al. A comparison of distinct bone marrow-derived cells on cartilage tissue
                   engineering. J Taiwan Inst Chem Eng 2017;78:32-8.
   568   569   570   571   572   573   574   575   576   577   578